Join us for an insightful presentation exploring the latest, practice-changing clinical trials that are reshaping the standards of care in breast cancer radiotherapy. The post Breast Radiotherapy in 2025: Integrating Landmark Trials and Technological Advances appeared first on Accuray Exchange.
Join our RTT webinar to learn about efforts to bring advanced practice RTs to the US and the advantages to practice they bring. The post Transforming Palliative Radiation Therapy: The Role and Impact of the Advanced Practice Radiation Therapist in the U.S. appeared first on Accuray Exchange.
Join us for a webinar presented by a leading expert in the use of the CyberKnife® System in the treatment of Trigeminal Neuralgia. The post Trigeminal Neuralgia: From Neural Storms to Radiosurgical Calm appeared first on Accuray Exchange.
In this presentation, the presenters will discuss the design, outcomes, and clinical implications of the phase II RADIOSA trial, which evaluated stereotactic body radiotherapy (SBRT) alone versus SBRT combined with short-course androgen deprivation therapy (ADT) in patients with hormone-sensitive oligo-recurrent prostate cancer. The post RADIOSA Trial and Beyond: Exploring the Full Potential of SBRT in Advanced Prostate Cancer appeared first on Accuray Exchange.
Le CHU de Saint-Quentin et le Centre Oscar Lambret partageront en détail leurs programmes de contrôle qualité pour les systèmes TomoTherapy® et Radixact®, mis en œuvre suite à la nouvelle décision de l’ANSM. The post Mise en place de la nouvelle décision ANSM pour les systèmes TomoTherapy® et Radixact® appeared first on Accuray Exchange.
Register now for the August webinar. The post CyberKnife® Radiosurgery for Non-functioning Pituitary Adenomas appeared first on Accuray Exchange.
Join us for an informative and interactive webinar exploring the latest proposed regulations from the Centers for Medicare & Medicaid Services (CMS) and their implications for the field of Radiation Oncology. The post CMS Proposed Rules and ROCR Updates appeared first on Accuray Exchange.
Join us for this informative review of the current evidence in SBRT for Gynecologic Cancers. The post Local Ablation in the Management of Primary and Metastatic Gynecologic Cancers: A Review of Evidence and Indications for Stereotactic Body Radiotherapy (SBRT) appeared first on Accuray Exchange.
Disclaimer: The statements in this forum do not necessarily reflect the views of, and are not endorsed by, Accuray Incorporated or its affiliates. Such statements are not and should not be construed as medical, legal or reimbursement advice. To protect your privacy and the privacy of others, we ask that you do not provide to Accuray and/or to other members on this forum any information which contain personally identifiable information, including protected health information (as defined in 45 CFR §160.103 or applicable international regulations) or any sensitive information. Any health economic and reimbursement information contained herein may not be current or accurate as a result of complex and frequently changing laws, rules and policies.
By posting and submitting any content or information, you agree to comply with the Accuray Exchange Terms of Use. Remove or block out any patient-identifying information such that it cannot be accessed.